Baker Bros. Capital (GP), LLC Insider Trading $SGEN Seagen Inc.
Get free email notifications about insider trading for Baker Bros. Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Bros. Capital (GP), LLC. Baker Bros. Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Baker Bros. Capital (GP), LLC in Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Bros. Capital (GP), LLC: Director
Holdings: 481,890 shares
Current Value: $29,294,093
Latest Transaction: May 04 2010
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Bros. Capital (GP), LLC in Seagen Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, HRTX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 04 2010 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.75 | 798 | 8,579 | 481,890 | 481.1 K to 481.9 K (+0.17 %) |
| May 20 2009 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.72 | 3,710 | 36,061 | 481,092 | 477.4 K to 481.1 K (+0.78 %) |
| Mar 19 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.02 | 141 | 1,131 | 477,382 | 477.2 K to 477.4 K (+0.03 %) |
| Mar 19 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 7.80 | 189 | 1,474 | 477,241 | 477.1 K to 477.2 K (+0.04 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.06 | 105 | 846 | 477,052 | 476.9 K to 477.1 K (+0.02 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.08 | 225 | 1,819 | 476,947 | 476.7 K to 476.9 K (+0.05 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 7.93 | 103 | 816 | 476,722 | 476.6 K to 476.7 K (+0.02 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 7.98 | 31 | 247 | 476,619 | 476.6 K to 476.6 K (+0.01 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.06 | 105 | 846 | 477,052 | 476.9 K to 477.1 K (+0.02 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.08 | 225 | 1,819 | 476,947 | 476.7 K to 476.9 K (+0.05 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 7.93 | 103 | 816 | 476,722 | 476.6 K to 476.7 K (+0.02 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 7.98 | 31 | 247 | 476,619 | 476.6 K to 476.6 K (+0.01 %) |
| Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.06 | 103 | 933 | 476,588 | 476.5 K to 476.6 K (+0.02 %) |
| Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.94 | 4 | 36 | 476,485 | 476.5 K to 476.5 K (0.00 %) |
| Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.00 | 238 | 2,143 | 476,481 | 476.2 K to 476.5 K (+0.05 %) |
| Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.00 | 70 | 630 | 476,243 | 476.2 K to 476.2 K (+0.01 %) |
| Jan 23 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.03 | 259 | 2,338 | 476,173 | 475.9 K to 476.2 K (+0.05 %) |
| Jan 23 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.78 | 160 | 1,404 | 475,914 | 475.8 K to 475.9 K (+0.03 %) |
| Jan 23 2008 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.00 | 4,747 | 42,723 | 475,754 | 471 K to 475.8 K (+1.01 %) |
| Jul 11 2007 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Option Exercise | C | 0.00 | 46,605 | 0 | 0 | |
| Jul 11 2007 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | C | 0.00 | 466,050 | 0 | 471,007 | 5 K to 471 K (+9,401.86 %) |
| Feb 16 2007 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Option Exercise | C | 0.00 | 7,800 | 0 | 46,605 | |
| Feb 16 2007 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Sell | S | 8.72 | 149,930 | 1,307,390 | 4,957 | 154.9 K to 5 K (-96.80 %) |
| Feb 16 2007 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | C | 0.00 | 78,000 | 0 | 154,887 | 76.9 K to 154.9 K (+101.45 %) |
Page: 1